About Us

The West Midlands Academic Health Science Network leads, catalyses and drives co-operation, collaboration and productivity between academia, industry, health and care providers and commissioners, and citizens, and accelerates the adoption of innovation to generate continuous improvement in the region’s health and wealth.

This will be achieved in a collaborative environment in which member organisations are mutually supportive and in which the technology-rich West Midlands’ life sciences community is fully integrated and generating additional investment. Innovation will be spread at scale and pace regionally, nationally and internationally. WMAHSN, its partners and the public will celebrate the region’s success as a centre for innovation, health and wealth and as the first digitally-enabled health economy in England. The improved generation and adoption of innovation will benefit the economy by giving the region’s academic institutions and life sciences industry a competitive advantage.

WMAHSN News

Information events for NHS commissioners and providers showcase how to procure cost-saving innovations

The NHS Innovation Accelerator (NIA) is to host a series of information events in partnership with local Academic Health Science Networks (AHSNs) - including one in Birmingham - to demonstrate how NHS commissioners and providers can be reimbursed for the…    Read More

Starting Anticoagulation with Jack video helps patients learn more about medicines

Anticoagulants are prescribed to prevent harmful blood clots that can lead to stroke. Patients and carers need advice and information about how these medicines work, and their potential side effects. Wessex AHSN, on behalf of the AHSN Network, has created…    Read More

Featured Programme

Meridian

Introducing Meridian

Meridian is the West Midlands’ online healthcare innovation exchange, supporting the adoption of good practice and the sharing of lessons learned.
Access Meridian

Latest video

Starting Anticoagulation with Jack

Anticoagulants are prescribed to prevent harmful blood clots that can lead to stroke. They are designed to prevent or treat clots, but can increase the risk of bleeding. Patients and carers need advice and information about how these medicines work, and their potential side effects. Starting Anticoagulation with Jack explains about clotting and why abnormal clots can form as people age. The different types of medicines are shown, and Jack and his son discuss common concerns, side effects and sources of support.

Events

21

June 2017

Clinical inertia

Macdonald Ansty Hall, Coventry CV7 9HZ

Part of the Diabetes up close and personalised education programme 2016 - 2017, this meeting looks at the barriers to…    Read More

10

May 2017

West Midlands CVD and diabetes event: adoption, innovation, dissemination

Canalside, The Cube, Mailbox, Birmingham B1 1RN

Hear from clinical leaders who've made change happen! The aims of the day are to learn from excellence in prevention…    Read More

Latest Tweets

Our newsletter